跨性别男性睾酮治疗期间卵巢组织卵母细胞体外成熟的可行性低
该横断面研究纳入83名跨性别男性,在性别确认手术时获取卵丘-卵母细胞复合体进行体外成熟和ICSI。体外成熟率23.8%,玻璃化率21.5%,正常受精率34.5%,仅获得1枚囊胚。卵母细胞发育能力低,且玻璃化率与孕酮负相关、与AMH正相关。
要点
- 睾酮治疗中跨性别男性的卵巢组织卵母细胞体外成熟率仅23.8%
- 正常受精率34.5%,仅1枚囊胚形成,胚胎发育潜能低
- 玻璃化率与孕酮负相关(OR 0.76),与AMH正相关(OR 1.23)
核心结论
- 在睾酮治疗下,跨性别男性的卵巢组织卵母细胞体外成熟后发育能力低。
研究设计与样本
- 横断面研究,纳入2015年11月至2019年1月期间的83名跨性别男性,在大学医院进行。
主要发现
- 共收集1903个COCs,平均每人23±15.8个;体外成熟率23.8%,玻璃化率21.5%, warming后存活率72.6%(n=151)。
- 对139个卵母细胞行ICSI,正常受精率34.5%,25个(52.1%)胚胎达到第3天,仅1个囊胚在第5天形成。
- 22个(45.8%)合子出现异常卵裂模式,44个(91.7%)出现早期胚胎停滞。
- 与玻璃化-warmed供卵母细胞相比,原核消失、t2、CC1和SS3时间间隔延迟;42%胚胎显示正常遗传模式。
- 玻璃化卵母细胞比例与孕酮负相关(OR 0.76),与AMH正相关(OR 1.23);第0天形态特征344和第2天433的玻璃化率最高。
临床怎么用
- 对于睾酮治疗中的跨性别男性,卵巢组织卵母细胞体外成熟用于生育力保存的可行性低,应充分告知。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the feasibility of in vitro maturation of ovarian tissue oocytes for fertility preservation in transgender men on testosterone treatment. DESIGN: Cross-sectional study SETTING: University hospital PATIENT(S): Eighty-three transgender men enrolled from November 2015 to January 2019 INTERVENTION(S): In vitro maturation of cumulus-oocyte complexes (COCs) harvested at the time of gender confirmation surgery, and fertilization through intracytoplasmic sperm injection. MAIN OUTCOME MEASURE(S): In vitro maturation, fertilization, and blastulation rates; comparison of morphokinetics with vitrified-warmed oocytes; and analysis of the genetic profiles of embryos. SECONDARY OUTCOMES: association between serum hormone levels; COCs' morphologic characteristics, and vitrification rate. RESULT(S): All participants were on testosterone treatment for a median of 83 (64[Quartile 1]; 113.2[Quartile 2]) weeks. A total of 1,903 COCs (mean per participant, 23 ± 15.8) were collected. The in vitro maturation rate was 23.8%, vitrification rate was 21.5%, and survival rate after warming was 72.6% (n = 151). Intracytoplasmic sperm injection was performed in 139 oocytes. The rate of normal fertilized oocytes was 34.5%, and 25 (52.1%) embryos reached day 3. One blastocyst was achieved on day 5. Aberrant cleavage patterns and early embryo arrest were observed in 22 (45.8%) and 44 (91.7%) zygotes, respectively. Compared with vitrified-warmed donor oocytes, a delay was observed in pronuclei disappearance, t2 (time to reach 2 cell stage) timings, and CC1 (the duration of the 1st cell cycle) and SS3 (synchronization of cleavage pattern (calculated as t8-t5) time intervals. A normal genetic pattern was seen in 42% embryos. The proportion of vitrified oocytes was negatively associated with progesterone (odds ratio, 0.76) and positively associated with antimüllerian hormone serum levels (odds ratio, 1.23). The highest vitrification rate was achieved by the morphologic characteristic 344 at day 0 and by 433 at day 2. CONCLUSION(S): Ovarian tissue oocytes matured in vitro show low developmental capacity in transgender men, when collected under testosterone treatment.
引用
- Lierman S, Tolpe A, De Croo I, et al. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men. Fertil Steril. 2021. PMID: 33832736. doi:10.1016/j.fertnstert.2021.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。